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22q11.2 deletion syndrome (22q11.2DS), also known as Velo-Cardio-Facial Syndrome 
(VCFS) or DiGeorge Syndrome, is a genetic disorder due to a micro deletion on chromosome 
22q11.2. VCFS is associated with abnormalities in brain structure and with an increased risk 
of psychiatric disorders, particularly schizophrenia (SCZ). DNA copy number is a largely 
unexplored source of human genetic variation that may contribute risk for complex disease 
like SCZ. The aim of this study was to assess Copy number variations (CNV) at candidate 
genes located in 22q11 region in SCZ subjects. We report aberrations in copy number at 
PRODH and COMT gene loci supporting the hypothesis that dosage effects of 22q genes 
could lead to disruptions in neurotransmitter signaling and related neurobehavioral 
symptoms observed in SCZ subjects. The results support the hypothesis that the complex 
phenotype of 22qDS results either from the overlapping  regulation of several genes within 
this region or from its concerted participation in a highly regulated process. 
 
Keywords- Velo-Cardio-Facial Syndrome (VCFS), 22q deletion syndrome, Schizophrenia(SCZ), 
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 Velo-Cardio-Facial Syndrome (VCFS) 
is caused by a 3 Mbp hemizygous 
microdeletion at 22q11. VCFS patients show 
an unusually high rate of psychiatric 
disorders, particularly SCZ and bipolar 
disorder; in fact, VCFS and the 22q11 deletion 
represent the highest known risk factor for 
SCZ aside from having either parents or a 
monozygotic twin with the disease (Drew et 
al., 2010). Several genes located in the 22q11 
chromosome regions have been studied and 
suggested as candidate genes for SCZ. A 
number of genes of the VCFS critical region 
on chromosome 22 are expressed in the 
developing and adult central nervous system, 
and potentially contribute to VCFS 
neuropsychiatric phenotypes (Maynard et al., 
2003 and Arinami, 2006). Given the 
remarkably high incidence of comorbid 
diagnoses of VCFS and SCZ, these 
associations are important clues about both 
the genesis of SCZ symptoms in VCFS and 
the neurogenetic mechanism of non VCFS-
related SCZ. 
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It is proposed that the 22q11 VCFS 
deletion may predispose to psychotic 
disorders through haplo-insufficiency of 
critical developmental genes in this region, or 
perhaps through unmasking of deleterious 
polymorphisms in the intact copy. Recent 
reports on the association of copy number 
variations (i.e. deletions/insertions) with 
genetic susceptibility to autism (Sebat et al., 
2007) and SCZ (Xu et al., 2010) have 
rekindled the interest in VCFS. The study of 
the molecular mechanisms causing the 
clinical manifestations of VCFS offers a 
unique opportunity to concentrate on a 
specific region in the genome that contains a 
limited number of genes, and to assess their 
relevance to chromosomal abnormalities as 
well as neuropsychiatric disorders. Several 
linkage studies highlight 22q12.3 as a region 
of interest for psychosis (Mowry et al., 2004; 
Fallin et al., 2005; Condra 2007). Further, 
meta-analyses point to chromosome 22q as 
harboring one or more genetic risk factors for 
SZC susceptibility (Badner and Gershon, 
2002; Lewis et al., 2003). Also, meta-analysis 
of magnetic resonance imaging studies in 
chromosome 22q11.2 deletion syndrome 
supports that volumetric brain abnormalities 
in VCFS is associated with a greatly increased 
risk of psychosis and other psychiatric 
disorders (Tan 2009). 
Copy number variations (CNVs) are 
deletions and duplications of DNA 
sequences that vary in length from few 
base pairs to several Mb. While these 
structural variations are often benign, 
they can disrupt vital biological functions 
and result in disease (Glessner et al., 
2012). Studies in vitro and in engineered 
mice show that CNVs affect genes in the 
duplicated region and flanking gene 
stretching to several Mb. Several CNV 
induced mechanisms that include 
physical dissociation of the transcription 
unit from its cis-acting regulators, 
chromatin modification /positioning 
within the nucleus have been suggested 
to influence the expression of genes. 
In the present study we carried out 
Copy number variation analysis of eight SCZ 
candidate region genes in the VCFS critical 
region viz., COMT (Catechol-Omethyl 
transferase), PRODH1 (Proline Dehydro-
genase (Oxidase)1, ZDHHC8 (The zinc finger 
and DHHC domain-containing protein 8) and 
CACNG2(calcium channel, voltage-
dependent, gamma subunit 2) and flanking 
genes in the distal breakpoint region viz., 
GGT2 (gamma-glutamyl transpeptidase 2). 
HIC2 (hypermethylated in cancer 2) and 
UBE2L3 ubiquitin-conjugating enzyme E2L 3.   
The gene coding catechol-Omethyl 
transferase (COMT) encodes two distinct 
COMT isoenzymes; membrane- bound 
COMT (MB-COMT) and soluble COMT (S-
COMT) (Bertocci et al., 1991). MB-COMT is 
primarily found in the brain. COMT is a 
plausible candidate susceptibility gene for 
SCZ given its positional association with 
22q11.2DS and its functional role cortical 
synaptic dopamine catabolism (Williams et 
al., 2007).  
The ZDHHC8 gene, codes for proline 
dehydrogenase, a mitochondrial membrane 
enzyme that catalyzes the first step in the 
proline degradation pathway (Bender et al., 
2005). Proline is a nonessential amino acid, 
which may have a role in brain function; as a 
modulator/ precursor of neuronal 
glutaminergic activity (Murphy and 
Scambler, 2005) and the regulation of cortical 
acetylcholinesterase function (Delwing et al., 
2003). Gogos et al. (1999) found that mice, 
which were homozygous ZDHHC8 mutants, 
had increased brain proline levels and had a 
significant decreased prepulse inhibition 
(PPI) of the startle reflex, suggestive of a 
defect in sensorimotor gating, an endo-
phenotype of scz. In addition, mice with 
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deletions in the 22q11.2 region showed severe 
sensorimotor gating defects, learning, and 
memory impairment (Paylor et al., 2001).  
The zinc finger and DHHC domain-
containing protein 8 (ZDHHC8) encodes for a 
transmembrane palmitoyltransferase, which 
is required for protein palmitoylation. 
Palmitoylation is a posttranslational 
modification of proteins with the lipid 
palmitate, a process which is required for 
protein interactions, signaling, neural 
development, neurotransmitter receptor 
function, and synaptic transmission (El-
Husseini and Bredt, 2002). ZDHHC8 is 
expressed in the adult human brain (Mukai et 
al., 2004) and is found predominantly in the 
cortex and hippocampus of the mouse brain 
(Karayiorgou and Gogos, 2004). ZDHHC8 has 
been proposed as a plausible candidate gene 
contributing to the behavioral phenotype of 
22q11.2.2DS, given its functional role and its 
association with PPI (Karayiorgou and 
Gogos, 2004).Furthermore, ZDHHC8 female 
knock-out mice showed significantly lower 
levels of PPI compared with wild types 
(Mukai et al., 2004). However, several studies 
have found no association with ZDHHC8 
variants and scz in the Japanese and 
European populations (Otani et al., 2005; 
Saito et al., 2005; Glaser et al., 2006b).   
The CACNG2 gene is the γ subunit of 
neuronal voltage activated L-type calcium 
channels, which might stabilize the calcium 
channel in an inactive state (Tomita et al., 
2010). The CACNG2 protein is similar to the 
mouse stargazin protein (Bedoukian et al., 
2006), which is also implicated in _-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptor trafficking.  
The AMPA receptor mediates fast 
excitatory synaptic transmission in the brain 
and underlies aspects of synaptic plasticity 
(Yamasaki et al., 2011). Protein interaction 
networks suggests that the CACNG2 
mediated AMPA receptor recruiting may act 
in the glutamatergic signaling process(Hsu 
2008).  
Gamma-glutamyl transpeptidase 2 
gene is involved in the degradation of 
glutathione. The encoded enzyme also acts as 
part of a GSH pumping gamma-glutamyl 
cycle in this tissue and may also be involved 
in gamma-glutamyl amino acid formation. 
HIC2(hypermethylated in cancer 2) the 
protein encoded by the gene has a histone 
deacetylase activity.  
UBE2L3 ubiquitin-conjugating 
enzyme E2L 3. The gene encodes a protein 
member of the E2 ubiquitin-conjugating 
enzyme family part of the cellular mechanism 
for targeting abnormal or short-lived proteins 
for degradation. 
Paterlini et al. (2005) reported an up-
regulation of COMT mRNA in the frontal 
cortex of ZDHHC8 mutant mice.  In addition, 
when tolcapone (a COMT inhibitor) was 
administered to the ZDHHC8 mutants, there 
was a greater disruption in PPI and working 
memory compared with the non-treated 
ZDHHC8 mutants suggesting a gene–gene 
interaction between ZDHHC8 and COMT. 
This is consistent with the proposal that 22q 
DS is a contiguous gene syndrome, in which 
deficiency in more than one gene contributes 
to the increased risk.  
Wilson et al. (2008) reported two 
patients with interstitial deletion of the 22q13 
region with intact SHANK3 indicates that 
haplo in sufficiency for other 22q13 genes 
could also have major effects on cognitive 
and language development. Above studies 
are consisted with the hypothesis that the 
phenotypic expression in VCFS in terms of 
cognition and co-morbidity can be affected 
by each gene alone and by interaction 
between genes that affect the same pathway 
(e.g., dopaminergic, glutamatergic). 
Cumulatively, these observations suggest the 
possible interaction of genes at the 22q locus 
and their role in the observed 
neuropsychiatric phenotype in VCFS. 
Further, Boolean network model of 
the biochemical pathway (neuro-
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transmitters) shows that, deletion/ 
knockout of certain biologically 
important nodes cause significant pertur-
bation in networks (Gupta et al., 2007) 
The molecular nature of the 
rearrangements responsible for 22q11 
microdeletions are related to the genomic 
structure which contains long stretches of 
repeated sequences clustered together, 
known as low copy repeats (LCRs) (Molina et 
al., 2011). LCRs contain highly repetitive 
elements such as short interspersed nuclear 
elements (SINEs) and long interspersed 
nuclear elements (LINEs). These elements, 
particularly SINEs have been implicated in 
chromosome rearrangements and disease. 
Alu elements, part of the SINE family of 
transposable elements, have also been 
established as having a role in modulating 
the architecture of the human genome in 
association with human disorders and in 
mediating gene rearrangements has been 
established (Batzer 2002). Further, Low-copy 
repeats (LCRs) on 22q11 have been suggested 
to mediate non-allelic homologous 
recombination (NAHR), resulting in 
rearrangements of 22q (Shaikh 2000).  
We have previously reported 
breakpoint associated with a novel 2.3 Mb 
deletion in the VCFS region of 22q11 and the 
role of Alu (SINE) in recurring microdeletions 
(Uddin 2006). Interestingly, not all LCRs 
appear to equally effect in causing 
microdeletions and they differ with respect to 
some of their sequences. Region-specific 
LCRs, repeat sequences, are susceptible to 
such genomic rearrangements resulting in 
CNVs. Factors such as size, orientation, 
percentage similarity and the distance 
between the copies renders them susceptible 
(Lee 2006). CNVs can be limited to a single 
gene or include a contiguous set of genes. 
This observation necessitates the assessment 
of the nature of individual LCRs elements 
around the candidate gene/s. CNVs can 
result in either too many or too few of the 
dosage sensitive genes, which may be 
responsible for a substantial amount of 
human phenotypic variability, complex 
behavioral traits, and disease susceptibility 
(Redon 2006). 
In the present study we report CNV 
analysis of SCZ candidate genes in the VCFS 
critical region involved in dopaminergic and 
glutamatergic neurotransmission. Further we 
characterized genomic sequences flanking the 
candidate genes to assess the nature of CNV 
formation. 
 
2. Materials and methods 
2.1 Ethical approval and Recruitment 
The study was conducted following 
approval by The University of Western 
Ontario Committee on Research Involving 
Human Subjects and all participating 
members provided informed consent for this 
research. The patients were identified and 
recruited by Dr. Richard O’Reilly and Dr. Jay 
Rao Psychiatrists. Clinical assessment was 
carried out using APA Diagnostic and 
Statistical Manual (DSM-IV) and their 
medical records.  
DNA extraction from whole blood of 
study cohort was carried out using perfect 
pure DNA blood kit (5prime.com)following 
manufacturers protocol and DNA quantified 
using a spectrophotometer using the 260/280 
nm ratio. 
 
2.2 CNV analysis 
CNV analysis was carried out using 
RealTime PCR with an internal control 
(RNASEP gene) using TaqMan detection 
chemistry and the ABI Prism 7300 Sequence 
Detection System (Applied Biosystems). 
Individual CNV PCRs of 18 µl were set up in 
triplicates in 48 well plates containing 20 ng 
genomic DNA (2 µl), 2✕ TaqMan® 
Genotyping Master Mix(10 µl), TaqMan® 
Copy Number Assay, 20✕ working Stock 
1µl, TaqMan® Copy Number Reference 
Assay 1µl, 20✕, Nuclease-free water 4 µl. 
Cycling conditions Hold 95oC 10 min, 
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Cycle(40 Cycles) 95 °C 15 sec, 60 °C 60 sec. 
The copy number of the test locus in each 
case was defined as 2T-∆∆C where ∆CT is the 
difference in threshold cycle number for the 
test and reference loci. 
 
2.3 Bioinformatics 
Further, to identify putative repeat 
elements in the flanking regions of CNVs the 
sequence features around the CNV, which 
could promote break points, deletion and 
duplication events was carried out using the  
http://genome.ucsc.edu/ (Build 37.1) and 
repeat masker http://www.repeatmasker. 
org/ 
 
3. Results 
The physical map of the 22Q region 
and genes under study are represented in 
figure-1.The results of the Copy number 
analysis are summarized in the table-1a. 
 
Table-1a Copy number analysis of candidate genes of 22q candidate genes in SCZ subjects 
 
 
 
Note-All samples have not worked for all genes. Bolded cells/genes indicate genes in Loss 
 
We found deletions at PRODH, 
COMT and ZDHHC8 genes. SNP analysis of 
PRODH gene is summarized in table 1b. 
 
Analysis of the repeat elements 
abutting the candidate genes suggests a 
constellation of repeats including the Short 
interspersed nuclear elements (SINE), which 
include Alu, Long terminal repeat elements 
(LTR), and L1 retrotransposons and repetitive 
DNA/RNA elements.  
The instability of 22q11 has been 
demonstrated by the high frequency of 
pathological rearrangements of this region. 
There is overwhelming evidence that 
hemizygosity of a large region on 22q11.2 
greatly increases the risk of SCZ and there is 
also evidence that VCFS is over represented 
in largely unselected SCZ populations. As 
hemizygosity changes the dosage of the 
genes in the region, one hypothesis is that 
this factor is related to susceptibility to SCZ. 
Sl.No Gene Copy Number (Loss/Gain) Cases(n=39) 
  Zero copy One copy Two copy Three Copy >3copy 
1 CACNG2  0 0 29 0 0 
2 PRODH  0 16 16 0 0 
3 COMT  0 6 33 0 0 
4 UBE2L3  0 1 32 0 0 
5 HIC2  0 1 32 0 0 
6 GGTL4  0 0 33 0 0 
7 ACTBL2  0 0 33 0 0 
8 ZDHH4  0 5 32 0 0 
 Gene Copy Number (Loss/Gain) Controls(n=96) 
  Zero copy One copy Two copy Three Copy >3copy 
1 CACNG2  0 1 29 1 0 
2 PRODH  3 29 62 2 0 
3 COMT  0 0 93 3 0 
4 UBE2L3  0 0 33 0 0 
5 HIC2  0 0 31 0 0 
6 GGTL4  0 0 30 0 0 
7 ACTBL2  0 0 31 0 0 
8 ZDHH4  0 3 92 1 0 
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In the absence of hemizygosity, either a null 
mutation or a sequence variant that lowers 
transcriptional activity would have similar 
effects.  
 
 
Figure 1. Candidate genes in the 22q region 
genotyped for copy number variation (CNV)  
 
Table-1b SNP analysis of PRODH candidate 
genes  in SCZ subjects 
 
 
PRODH, and ZDHHC8 genes in the 
1.5 Mb region of chromosome 22 encode 
mitochondrial proteins. They are expressed 
in the brain, and maximal expression 
coincides with peak forebrain synaptogenesis 
shortly after birth. Furthermore, their protein 
products are associated with brain 
mitochondria, including those in synaptic 
terminals. Distinct expression patterns and 
dynamic expression levels of these genes in 
the developing and adult brain suggest they 
contribute to construction and maintenance 
of neural circuits across synapses. 
 
Diminished dosage of the genes 
deleted in the 1.5-megabase 22q11 minimal 
critical deleted region in a mouse model of 
22q11DS demonstrate aberrations in 
neurogenesis and subsequent differentiation 
in the cerebral cortex. Such developmental 
disruption may alter cortical circuitry and 
establish vulnerability for developmental 
disorders, including SCZ and autism 
(Meechan et al., 2009). Further it is 
documented that CNVs can also result in a 
position effect (Kleinjan and Heyningen 
2005). Bottom-up approaches to define gene–
brain relationship investigating the 
relationship between genes and the neural 
substrates have provided essential insight 
into the pathophysiology of mental disorders 
in VCFS. Dosage-dependent Copy-number 
gain resulted in a discrete clinical phenotype 
of MECP2 duplication syndrome in an 
individual gene present in the larger genomic 
aberration (Vandewalle et al., 2009). As 
evidenced from table-1a, loss of CNV was 
observed at several genes at the 22q locus, 
however; the CNV copy number varied for 
each gene.  
We found high preponderance of Alu 
family of repetitive DNA viz., AluY, Alujo, 
Alujr, Alujb, Alusc, Alujy around the 
candidate genes. The presence of Alu repeats 
suggests proclivity for secondary-structure 
formation and serve as hotspots for 
chromosomal rearrangement. 
Alu elements, part of the SINE family 
of transposable elements have been shown to   
modulate the architecture of the human 
genome, gene rearrangements and associated 
with human disorders (Kolomietz 2002). We 
SNP Contig Position on 
ENSEMBL/Mutation 
Patients 
(n=10) 
Controls 
(n=6) 
1 2053870/E428G 0 1 
2 2053864/A430V 1 0 
3 2053858/R432H 0 1 
4 2053861/R431H/ 
rs2904552 
3 1 
5 2053739/A472T/ 
rs2870983 
1 0 
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find evidence for both, microhomology based 
nonallelic homologous recombination 
(NAHR) and microhomology mediated break 
induced replication (MMBIR) and fork 
stalling and template switching (FoSTeS) 
mechanisms for CNV loss. Different class of 
repeats viz., the endogenous retroviruses 
(HERV-K (also known as ERVK), L1 
retrotransposons and family of low 
complexity repeats (GC, AT rich) were also 
enriched flanking the candidate genes. 
Repetitive elements DNA-(MER1B, hAT-
Charlie) repeat-a class of transposable 
elements (TEs) which are interspersed 
repetitive DNA families and RNA (U3 
family) repeats were found flanking the 
ZDHHC8 gene providing further credence to 
the hypothesis that these repeats could 
predispose genomes to CNV through 
replication slippage or unequal crossing-over. 
 
Functional analysis of polymorphisms 
in the promoter regions of genes on 22q11 
suggests that the ZDHHC8 gene showed 
activity differences between haplotypes of 
greater than 1.5-fold.This implies that 
structural variations that modulate the rate of 
transcription of a gene may be found in the 
upstream of the gene (Hoogendoorn et al., 
2004). 
 
Discussion 
The 22q region continues to attract interest in 
schizophrenia research by virtue of its 
involvement in common micro deletions (e.g. 
deletion in 22q11), presence of unusual 
repeats, and as a potential site responsible for 
a number of clinically overlapping 
phenotypes. Our results are consistent with 
the hypothesis that genetic contribution from 
more than one gene at 22q11 region increase 
the risk for SCZ. Genomic lesions associated 
with significant risk for SCZ and other 
behavioral disorders have been shown to 
map to specific chromosomal segments 
(Girirajan et al., 2010). Recent CNV data 
(Babatz 2009 and data from our lab 
corroborate this observation (Maiti et al. 
2011). Our study has a few limitations as we 
have done this analysis on a small cohort of 
patients. Further replication in a larger cohort 
is required to confirm the results. Also given 
RealTime-PCR has not worked for all 
samples is a reflective of the sensitivity of the 
methodology. 
 
Further scrutiny of the aberrations 
and their functional consequences including 
the role of miRNA will lead to a better 
understanding of the etiology of psychiatric 
diseases in VCFS syndrome. Future, 
functional studies assessing the stoichiometry 
of gene products resulting from the gene 
imbalance would enable functional 
elucidation of the role of genes in SCZ. 
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